NZ252717A - Adamantane-pyridine derivatives and medicaments - Google Patents
Adamantane-pyridine derivatives and medicamentsInfo
- Publication number
- NZ252717A NZ252717A NZ252717A NZ25271793A NZ252717A NZ 252717 A NZ252717 A NZ 252717A NZ 252717 A NZ252717 A NZ 252717A NZ 25271793 A NZ25271793 A NZ 25271793A NZ 252717 A NZ252717 A NZ 252717A
- Authority
- NZ
- New Zealand
- Prior art keywords
- mmol
- compounds
- adamantyl
- pct
- ether
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Reproductive Health (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Cosmetics (AREA)
- Enzymes And Modification Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929210489A GB9210489D0 (en) | 1992-05-15 | 1992-05-15 | Heterocyclic compounds,their preparation and pharmaceutical use |
| GB929223738A GB9223738D0 (en) | 1992-11-12 | 1992-11-12 | Heterocyclic compounds,their preparation and pharmaceutical use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ252717A true NZ252717A (en) | 1996-05-28 |
Family
ID=26300892
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ252717A NZ252717A (en) | 1992-05-15 | 1993-04-29 | Adamantane-pyridine derivatives and medicaments |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5595995A (https=) |
| EP (1) | EP0640072B1 (https=) |
| JP (1) | JPH07506588A (https=) |
| KR (1) | KR100235976B1 (https=) |
| AT (1) | ATE195728T1 (https=) |
| AU (1) | AU673837B2 (https=) |
| CA (1) | CA2134563A1 (https=) |
| DE (1) | DE69329281T2 (https=) |
| ES (1) | ES2149817T3 (https=) |
| IL (1) | IL105666A (https=) |
| MX (1) | MX9302833A (https=) |
| NO (1) | NO302069B1 (https=) |
| NZ (1) | NZ252717A (https=) |
| TW (1) | TW223631B (https=) |
| WO (1) | WO1993023375A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE203530T1 (de) * | 1996-05-28 | 2001-08-15 | Pfizer | Adamantyl substituierte oxindole als pharmazeutische wirkstoffe |
| US7795468B2 (en) * | 2001-01-19 | 2010-09-14 | Chevron U.S.A. Inc. | Functionalized higher diamondoids |
| US6864264B1 (en) * | 2002-08-20 | 2005-03-08 | Gloria L. Anderson | 1-adamantyl chalcones for the treatment of proliferative disorders |
| JP2006160605A (ja) * | 2003-07-09 | 2006-06-22 | Nippon Kayaku Co Ltd | 新規酵素阻害剤 |
| JP2008007404A (ja) * | 2004-10-08 | 2008-01-17 | Nippon Kayaku Co Ltd | 新規ピリジン誘導体 |
| CN101248041B (zh) | 2005-06-17 | 2013-11-20 | 艾宝奇生物工艺有限公司 | 鞘氨醇激酶抑制剂 |
| GB0803494D0 (en) * | 2008-02-26 | 2008-04-02 | Sterix Ltd | Compound |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3971797A (en) * | 1973-06-15 | 1976-07-27 | Merck & Co., Inc. | S,S'-bis(pyridylmethyl)-carbonodithioates |
| US4797411A (en) * | 1986-07-18 | 1989-01-10 | Farmitalia Carlo Erba S.P.A. | Cycloalkyl-substituted 4-pyridyl derivatives and use as aromatase inhibitors |
| DE4018260A1 (de) * | 1990-06-07 | 1991-12-12 | Basf Ag | Derivate des (beta)-picolins und diese enthaltende pflanzenschutzmittel |
-
1993
- 1993-04-29 NZ NZ252717A patent/NZ252717A/en unknown
- 1993-04-29 KR KR1019940704105A patent/KR100235976B1/ko not_active Expired - Fee Related
- 1993-04-29 CA CA002134563A patent/CA2134563A1/en not_active Abandoned
- 1993-04-29 AU AU42674/93A patent/AU673837B2/en not_active Ceased
- 1993-04-29 JP JP5519965A patent/JPH07506588A/ja active Pending
- 1993-04-29 ES ES93911885T patent/ES2149817T3/es not_active Expired - Lifetime
- 1993-04-29 DE DE69329281T patent/DE69329281T2/de not_active Expired - Fee Related
- 1993-04-29 WO PCT/GB1993/000890 patent/WO1993023375A1/en not_active Ceased
- 1993-04-29 EP EP93911885A patent/EP0640072B1/en not_active Expired - Lifetime
- 1993-04-29 US US08/335,743 patent/US5595995A/en not_active Expired - Fee Related
- 1993-04-29 AT AT93911885T patent/ATE195728T1/de not_active IP Right Cessation
- 1993-04-30 TW TW082103369A patent/TW223631B/zh active
- 1993-05-11 IL IL10566693A patent/IL105666A/en not_active IP Right Cessation
- 1993-05-14 MX MX9302833A patent/MX9302833A/es not_active IP Right Cessation
-
1994
- 1994-11-14 NO NO944332A patent/NO302069B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR100235976B1 (ko) | 1999-12-15 |
| IL105666A (en) | 1999-09-22 |
| KR950701620A (ko) | 1995-04-28 |
| DE69329281T2 (de) | 2001-03-15 |
| JPH07506588A (ja) | 1995-07-20 |
| DE69329281D1 (de) | 2000-09-28 |
| ATE195728T1 (de) | 2000-09-15 |
| NO944332D0 (no) | 1994-11-14 |
| CA2134563A1 (en) | 1993-11-25 |
| IL105666A0 (en) | 1993-09-22 |
| AU673837B2 (en) | 1996-11-28 |
| WO1993023375A1 (en) | 1993-11-25 |
| EP0640072B1 (en) | 2000-08-23 |
| NO302069B1 (no) | 1998-01-19 |
| US5595995A (en) | 1997-01-21 |
| ES2149817T3 (es) | 2000-11-16 |
| NO944332L (no) | 1994-11-14 |
| MX9302833A (es) | 1993-11-01 |
| AU4267493A (en) | 1993-12-13 |
| EP0640072A1 (en) | 1995-03-01 |
| TW223631B (https=) | 1994-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Conti et al. | Synthesis of new Δ2-isoxazoline derivatives and their pharmacological characterization as β-adrenergic receptor antagonists | |
| Rowlands et al. | Esters of 3-pyridylacetic acid that combine potent inhibition of 17. alpha.-Hydroxylase/C17, 20-lyase (Cytochrome P45017. alpha.) with resistance to esterase hydrolysis | |
| McCague et al. | Inhibition of enzymes of estrogen and androgen biosynthesis by esters of 4-pyridylacetic acid | |
| EP0706795A2 (en) | Catechol diether compounds as inhibitors of TNF release | |
| EP1659113A1 (en) | Inhibitors of 11beta-hydroxy steroid dehydrogenase type 1 (11beta-HSD1) | |
| JP5066638B2 (ja) | ピリジン−１−オキシド誘導体及びその医薬的に有効な化合物へと転換する為の方法 | |
| US5972975A (en) | Substituted 2-aminopyridines as inhibitors of nitric oxide synthase | |
| Bagal et al. | Syntheses of the enantiomers of 1-deoxynojirimycin and 1-deoxyaltronojirimycin via chemo-and diastereoselective olefinic oxidation of unsaturated amines | |
| NZ252717A (en) | Adamantane-pyridine derivatives and medicaments | |
| KR100224153B1 (ko) | 6,9-비스[(2-아미노에틸)아미노]벤조[g]이소퀴놀린-5,10-디온및 이의 디말레산염의 개선된 합성 방법 | |
| SK12022001A3 (sk) | 2-aminopyridíny obsahujúce ako substituenty kondenzované kruhové skupiny | |
| US5004748A (en) | Substituted pyridine-2,4-dicarboxylic acid derivatives and medicaments based on these compounds | |
| US10214496B2 (en) | Azasteroidal mimics | |
| JPS6233172A (ja) | ド−パミン−β−ヒドロキシラ−ゼ抑制剤 | |
| IE892539L (en) | New 6-fluoro-3,5-dihydroxy carboxylic acids and derivatives¹thereof, a process for the preparation thereof, the use¹thereof as medicinal agents, pharmaceutical products and¹intermediates | |
| Deraeve et al. | Chemical synthesis, biological evaluation and structure–activity relationship analysis of azaisoindolinones, a novel class of direct enoyl-ACP reductase inhibitors as potential antimycobacterial agents | |
| GB2266887A (en) | Substituted pyridines, their preparation and pharmaceutical use | |
| FR2806722A1 (fr) | Derives de n-(heterocyclylbutyl) benzene-ou pyridine sulfonamide, leur preparation et leur application en therapeutique | |
| AP1208A (en) | 2-Aminopyridines containing fused ring substituents | |
| WO2001096309A1 (en) | Hydroxyformamidine derivatives and medicines containing the same | |
| EP2516400A1 (fr) | Dérivés phénoliques, et leur utilisation pharmaceutique ou cosmétique | |
| JPH0393773A (ja) | 置換アミノピリジン類 | |
| JPH0366668A (ja) | イミノ置換ピリジン類 | |
| US5409910A (en) | Substituted pyridines | |
| EP1448550B1 (fr) | Tetrahydropyridyl-alkyl-heterocycles azotes avec une activite du tnf |